Pamisel, Foreigners Net Buy 25,000 Shares... Stock Price -2.52%

Pamissel has ranked among the top searched stocks for 9 days in the past month.

As of 2:30 PM on the 7th, Pamissel is trading at 21,300 KRW, down 2.52% from the previous day. This represents an 11.23% increase compared to November 9. Pamissel is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net buyers of 25,000 shares. Over the past 5 days, individual investors have net purchased 116,230 shares, while foreigners and institutions have net sold 128,941 shares and net purchased 23,308 shares, respectively.

On December 3, Pamissel was a market topic with the headline "Strong performance following approval of phase 3 clinical trial for cirrhosis stem cell therapy."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.